ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Scope & Guideline

Connecting Researchers to the Heart of Life Sciences Discovery.

Introduction

Delve into the academic richness of ACTA BIOCHIMICA ET BIOPHYSICA SINICA with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1672-9145
PublisherSCIENCE PRESS
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationACTA BIOCH BIOPH SIN / Acta Biochim. Biophys. Sin.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING 100009, PEOPLES R CHINA

Aims and Scopes

ACTA BIOCHIMICA ET BIOPHYSICA SINICA focuses on the biochemical and biophysical aspects of biological processes, offering insights into molecular mechanisms underlying various diseases and therapeutic approaches.
  1. Glycosylation and its Implications:
    The journal has a strong emphasis on the role of glycosylation in disease mechanisms, particularly in cancer and neurodegenerative diseases. This includes studies on glyco-signatures and post-translational modifications that influence cellular functions.
  2. Cancer Biology and Therapeutics:
    A significant portion of the research is dedicated to understanding cancer biology, including tumor microenvironments, resistance mechanisms, and potential therapeutic targets. The journal publishes studies on cellular signaling pathways involved in cancer progression.
  3. Immunology and Inflammation:
    The journal covers research related to immune responses in various contexts, including cancer immunotherapy, autoimmune diseases, and inflammatory responses. This includes studies on macrophage polarization and the role of immune cells in disease progression.
  4. Metabolism and Disease:
    Research on metabolic pathways and their implications in diseases such as diabetes, obesity, and cardiovascular diseases is prevalent. This includes studies on metabolic reprogramming in cancer and the impact of dietary components on health.
  5. Molecular Mechanisms and Target Identification:
    The journal emphasizes the molecular mechanisms of action for various compounds, including natural products and synthetic drugs, aiming to identify new therapeutic targets for disease management.
Recent publications in ACTA BIOCHIMICA ET BIOPHYSICA SINICA reveal several emerging themes that indicate a shift towards more innovative and relevant areas of research.
  1. Glycosylation as a Therapeutic Target:
    Research on glycosylation has surged, particularly in its role in cancer and immune responses. This includes studies that explore glycosylation patterns as potential biomarkers and therapeutic targets, highlighting its significance in personalized medicine.
  2. Metabolic Reprogramming in Cancer:
    There is a growing focus on the intersection of metabolism and cancer biology, with studies exploring how metabolic changes drive tumorigenesis and treatment resistance. This area is increasingly relevant as researchers seek to understand cancer metabolism for therapeutic interventions.
  3. Cellular Mechanotransduction:
    Emerging studies are focusing on how mechanical forces influence cellular behavior, particularly in cancer and tissue regeneration. This theme reflects an interdisciplinary approach combining biology, physics, and engineering to understand cellular responses.
  4. Role of Non-Coding RNAs:
    Research on non-coding RNAs, particularly in the context of cancer and metabolic diseases, is gaining momentum. These studies are exploring their roles in gene regulation and potential as therapeutic targets.
  5. Immunotherapy and Immune Modulation:
    There is a significant increase in research related to immunotherapy, particularly in relation to cancer treatment. This includes studies on immune checkpoint inhibitors, CAR-T cell therapies, and the modulation of immune responses to enhance therapeutic efficacy.

Declining or Waning

While ACTA BIOCHIMICA ET BIOPHYSICA SINICA maintains a broad focus, certain themes have shown a decline in prominence in recent publications, reflecting shifts in research interests.
  1. Traditional Medicinal Approaches:
    There has been a noticeable decrease in studies exclusively focused on traditional Chinese medicine compared to previous years. This may suggest a shift towards more modern, mechanistic studies that integrate traditional knowledge with contemporary scientific methods.
  2. Basic Biochemical Techniques:
    Research that primarily focuses on basic biochemical techniques without application to specific diseases or therapeutic contexts appears to be waning. There is a trend towards more applied research that connects biochemical findings with clinical relevance.
  3. Animal Models in Basic Research:
    The use of animal models for purely basic research has seen a decline, likely due to increasing emphasis on translational research and the need for more human-relevant models that can better predict clinical outcomes.

Similar Journals

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Exploring the molecular mechanisms that shape our world.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

FEBS Open Bio

Nurturing collaboration in the evolving landscape of biosciences.
Publisher: WILEYISSN: 2211-5463Frequency: 1 issue/year

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

Annual Review of Biochemistry

Connecting Past Discoveries with Future Innovations
Publisher: ANNUAL REVIEWSISSN: 0066-4154Frequency: 1 issue/year

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.

FASEB BioAdvances

Pioneering Discoveries in Physiology and Genetics
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Empowering Researchers with Cutting-Edge Discoveries
Publisher: TAYLOR & FRANCIS LTDISSN: 1381-3455Frequency: 5 issues/year

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Connecting Ideas, Inspiring Innovations in Molecular Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Elevating Insights in Molecular Biology
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

International Journal of Biological Sciences

Elevating Understanding in Biological Sciences
Publisher: IVYSPRING INT PUBLISSN: 1449-2288Frequency: 10 issues/year

International Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Pioneering Research in Biochemistry and Cell Dynamics
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.

BMB Reports

Advancing the Frontiers of Biochemistry and Molecular Biology
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.